Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid Leukemia
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid Leukemia
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 5, Pages 1247
Publisher
MDPI AG
Online
2020-05-15
DOI
10.3390/cancers12051247
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting FLT3 mutations in AML: review of current knowledge and evidence
- (2019) Naval Daver et al. LEUKEMIA
- Mechanisms of drug resistance in acute myeloid leukemia
- (2019) Jing Zhang et al. OncoTargets and Therapy
- Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia
- (2019) Nicole A. McNeer et al. LEUKEMIA
- Targeting CLL-1 for acute myeloid leukemia therapy
- (2019) Hongbing Ma et al. Journal of Hematology & Oncology
- g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)
- (2019) Uku Raudvere et al. NUCLEIC ACIDS RESEARCH
- Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine
- (2019) May Levin et al. Cell Death & Disease
- The role of cladribine in acute myeloid leukemia: an old drug up to new tricks
- (2019) Matteo Molica et al. LEUKEMIA & LYMPHOMA
- Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012
- (2018) Mareike Rasche et al. LEUKEMIA
- MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia
- (2018) Fiona C. Brown et al. Cancer Discovery
- Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
- (2017) Thomas Farge et al. Cancer Discovery
- Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome
- (2017) Patricia Macanas-Pirard et al. Oncotarget
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data
- (2016) Zuguang Gu et al. BIOINFORMATICS
- E2f8 mediates tumor suppression in postnatal liver development
- (2016) Lindsey N. Kent et al. JOURNAL OF CLINICAL INVESTIGATION
- SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
- (2016) Constanze Schneider et al. NATURE MEDICINE
- Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer
- (2016) I Thurlings et al. ONCOGENE
- Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition
- (2016) Liping Ye et al. Oncotarget
- TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia
- (2016) Ming Chu et al. Oncotarget
- Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma
- (2016) Yu Xia et al. Scientific Reports
- Geraniol suppresses prostate cancer growth through down-regulation of E2F8
- (2016) Sanghoon Lee et al. Cancer Medicine
- Hypoxia and Hypoxia-Inducible Factors in Leukemias
- (2016) Margaux Deynoux et al. Frontiers in Oncology
- Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance
- (2015) Anna Wojtuszkiewicz et al. INTERNATIONAL JOURNAL OF CANCER
- E2F8 as a Novel Therapeutic Target for Lung Cancer
- (2015) Sin-Aye Park et al. JNCI-Journal of the National Cancer Institute
- E2F8 as a Novel Therapeutic Target for Lung Cancer
- (2015) Sin-Aye Park et al. JNCI-Journal of the National Cancer Institute
- Gene Expression Profiles Associated with Pediatric Relapsed AML
- (2015) Costa Bachas et al. PLoS One
- Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance
- (2014) Lin-Hai Yan et al. BMC CANCER
- The Role of STAT3 Signaling in Mediating Tumor Resistance to Cancer Therapy
- (2014) Fiona Tan et al. CURRENT DRUG TARGETS
- STRING v10: protein–protein interaction networks, integrated over the tree of life
- (2014) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia
- (2014) L. Ma et al. Science Translational Medicine
- Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
- (2013) Murielle Mimeault et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group
- (2013) Gertjan J.L. Kaspers et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of a 24-Gene Prognostic Signature That Improves the European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: An International Collaborative Study
- (2013) Zejuan Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- E2F1 drives chemotherapeutic drug resistance via ABCG2
- (2013) M T Rosenfeldt et al. ONCOGENE
- Correction: Atypical E2fs Control Lymphangiogenesis through Transcriptional Regulation of Ccbe1 and Flt4
- (2013) Bart G. M. W. Weijts et al. PLoS One
- ABC transporters and their role in nucleoside and nucleotide drug resistance
- (2012) Yu Fukuda et al. BIOCHEMICAL PHARMACOLOGY
- Childhood acute myeloid leukaemia
- (2012) Jeffrey E. Rubnitz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pediatric acute myeloid leukemia
- (2012) Gertjan JL Kaspers Expert Review of Anticancer Therapy
- Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study
- (2012) Jerzy Holowiecki et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of minor subpopulations within the leukemic blast compartment of AML patients at initial diagnosis in the development of relapse
- (2012) C Bachas et al. LEUKEMIA
- E2F1 apoptosis counterattacked: evil strikes back
- (2012) Brigitte M. Pützer et al. TRENDS IN MOLECULAR MEDICINE
- ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer
- (2012) Maria Kalyuga et al. PLOS BIOLOGY
- High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients
- (2011) S. M. Noordermeer et al. BLOOD
- The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia
- (2011) B V Balgobind et al. LEUKEMIA
- Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes
- (2011) Jatinder K Lamba et al. PHARMACOGENOMICS
- Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia
- (2010) B. V. Balgobind et al. HAEMATOLOGICA
- The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression
- (2010) Ankur Sharma et al. JOURNAL OF CLINICAL INVESTIGATION
- High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome
- (2010) B V Balgobind et al. LEUKEMIA
- E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases
- (2009) Shweta Tyagi et al. EMBO JOURNAL
- Genetic factors influencing cytarabine therapy
- (2009) Jatinder K Lamba PHARMACOGENOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now